This article provides a comprehensive overview of induced pluripotent stem cell (iPSC) models and their transformative role in Parkinson's disease (PD) research.
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are revolutionizing cardiovascular research by providing a patient-specific, human-relevant platform for disease modeling and drug development.
Human induced pluripotent stem cells (iPSCs) have revolutionized the study of Alzheimer's disease (AD), enabling researchers to model amyloid-beta (Aβ) deposition in a patient-specific context.
This article provides a comprehensive overview of how human induced pluripotent stem cells (iPSCs) are revolutionizing the study of neurodevelopmental disorders (NDDs).
Patient-specific induced pluripotent stem cells (iPSCs) are revolutionizing the study and treatment of neurodegenerative diseases.
Human induced pluripotent stem cells (hiPSCs) have emerged as a transformative platform for investigating the mechanistic roles of Apolipoprotein E (APOE) isoforms in Alzheimer's Disease (AD) and other neurodegenerative conditions.
This article provides a comprehensive resource for researchers and drug development professionals on utilizing induced pluripotent stem cells (iPSCs) to model rare genetic diseases.
This article synthesizes current research on modeling tau hyperphosphorylation using human induced pluripotent stem cell (iPSC)-derived neurons, a system that recapitulates key aspects of Alzheimer's disease and related tauopathies.
This article provides a comprehensive analysis of human induced pluripotent stem cell (hiPSC) models for both familial (FAD) and sporadic (SAD) Alzheimer's disease.
This article provides a comprehensive analysis of how induced pluripotent stem cell (iPSC) models are revolutionizing Alzheimer's disease (AD) research.